Zoetis (ZTS) Retained Earnings (2012 - 2026)
Zoetis (ZTS) reported Retained Earnings of -$772.0 million for Q1 2026, up 24.09% year-over-year from -$622.1 million in Q1 2025, and up 3.98% quarter-over-quarter from -$804.0 million in Q4 2025.
Zoetis (ZTS) Retained Earnings (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Retained Earnings data on file, last reported at -$772.0 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$772.0 million, up 24.09% year-over-year; the trailing twelve-month figure through Mar 2026 was -$772.0 million (up 24.09% YoY), and the FY2025 annual result was -$804.0 million, up 14.47% from the prior year.
- Retained Earnings improved to -$772.0 million in Q1 2026 per ZTS's latest filing, from -$804.0 million in the prior quarter.
- Over five years, Retained Earnings peaked at $13.6 billion in Q3 2025 and troughed at -$1.0 billion in Q1 2025.
- A 5-year average of $2.4 billion and a median of -$804.0 million in 2025 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2023 and 2025: Retained Earnings tumbled 2146.34% in 2023, then jumped 1697.3% in 2025.
- A 5-year view of Retained Earnings shows it stood at $41.0 million in 2022, then plunged by 2146.34% to -$839.0 million in 2023, then decreased by 12.04% to -$940.0 million in 2024, then increased by 14.47% to -$804.0 million in 2025, then increased by 3.98% to -$772.0 million in 2026.
- Business Quant data shows ZTS's Retained Earnings at -$772.0 million in Q1 2026, -$804.0 million in Q4 2025, and $13.6 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | -573.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -772.00 Mn |
| Dec 31, 2025 | -804.00 Mn |
| Sep 30, 2025 | 13.59 Bn |
| Jun 30, 2025 | -877.00 Mn |
| Mar 31, 2025 | -1.02 Bn |
| Dec 31, 2024 | -940.00 Mn |
| Sep 30, 2024 | -851.00 Mn |
| Jun 30, 2024 | 11.12 Bn |
| Mar 31, 2024 | -841.00 Mn |
| Dec 31, 2023 | -839.00 Mn |
| Sep 30, 2023 | -814.00 Mn |
| Jun 30, 2023 | -895.00 Mn |
| Mar 31, 2023 | 9.05 Bn |
| Dec 31, 2022 | 41.00 Mn |
| Sep 30, 2022 | 8.53 Bn |
| Jun 30, 2022 | -722.00 Mn |
| Mar 31, 2022 | 7.63 Bn |
| Dec 31, 2021 | -756.00 Mn |
| Sep 30, 2021 | 7.04 Bn |
| Jun 30, 2021 | 6.49 Bn |